July 17, 2026

Effect of Socioeconomic Status on SGLT2 Initiation in Heart Failure

A nationwide German claims analysis found lower initiation of guideline-recommended sodium-glucose cotransporter-2 inhibitors among women and patients living in lower-income municipalities.

Conexiant

July 16, 2026

Remote Testing May Capture Subtle Changes in Early Alzheimer’s Disease

Remote assessments detected memory changes over 30 weeks in patients with mild cognitive impairment, whereas conventional neuropsychological testing did not detect differences in short-term decline.

Conexiant

July 16, 2026

A Sales Tax on Doctor Visits and Medicine? In Missouri, Some Worry

Voters will decide whether to expand lawmakers' authority to tax currently exempt healthcare goods and services, raising concerns about patient costs and healthcare access.

Kff Health News

July 15, 2026

Joint Site May Influence RA Treatment Response

A Swiss registry study found that the wrist and second and third metacarpophalangeal joints consistently resolved more slowly than most other joints following biologic or targeted synthetic therapy.

Conexiant

July 14, 2026

Are GLP-1s Linked to Optic Neuropathy?

A nationwide Swedish cohort found a higher relative risk of anterior ischemic optic neuropathy among GLP-1 receptor agonist users, but the overall risks were low.

Conexiant

July 09, 2026

Can AI Aid Urine Drug Test Sign-Outs?

Researchers reported that an artificial intelligence workflow maintained high interpretive accuracy while reducing urine drug test sign-out time in a supervised clinical laboratory setting.

Conexiant

July 09, 2026

Mental Health May Impact Dermatologic Quality of Life

Poorer dermatology-related quality of life was associated with greater mental health issues, while habitual probiotic intake showed no measurable relationship with these outcomes.

Conexiant

July 09, 2026

Prolonged Sleep Restriction May Increase Body Weight

In a pooled analysis of two randomized crossover trials, reducing nightly sleep by about 1.5 hours for 6 weeks was associated with modest increases in body weight and waist circumference without measurable changes in body composition.

Conexiant

July 08, 2026

Do Systemic Alpha-2 Agonists Lower Glaucoma Risk?

A large US cohort study found systemic alpha-2 agonist use was associated with a lower hazard of glaucoma-related diagnoses vs. beta-blockers.

Conexiant

July 07, 2026

Benchmark for Functional Vision Loss Uncovered in Older Adults

A nationally representative US cohort identified a contrast sensitivity threshold associated with self-reported visual disability.

Conexiant